Nidhi Nandu

Dr. Nidhi Nandu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
MHMustafa Salih Hizir
Mustafa Salih Hizir
NNNidhi Nandu
Nidhi Nandu
MYMehmet Veysel Yigit
Mehmet Veysel Yigit

5 November 2018 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
NNNidhi Nandu
Nidhi Nandu
MHMustafa Salih Hizir
Mustafa Salih Hizir
NRNeil M. Roberston
Neil M. Roberston
BOBirol Ozturk
Birol Ozturk
MYMehmet V. Yigit
Mehmet V. Yigit


12 September 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MKMahera J. Kachwala
Mahera J. Kachwala
CSChristopher Smith
Christopher Smith
NNNidhi Nandu
Nidhi Nandu
MYMehmet V. Yigit
Mehmet V. Yigit
A highly modular, 4 h-long ‘recombinase amplified CRISPR enhanced chain reaction’ (RACECAR) assay that can detect as little as 40 copies of hepatitis B virus (HBV) genome has been developed.

17 May 2019 in Journal of Analysis and Testing
Verified
Journal Article
Closed access
PDF file
CSChristopher Smith
Christopher Smith
YCYu-Sheng Chen
Yu-Sheng Chen
NNNidhi Nandu
Nidhi Nandu
MKMahera Kachwala
Mahera Kachwala
MYMehmet V. Yigit
Mehmet V. Yigit

22 October 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NNNidhi Nandu
Nidhi Nandu
MMMichael Miller
Michael Miller
YTYanhong Tong
Yanhong Tong
ZLZhi-Xiang Lu
Zhi-Xiang Lu
Cost efficient and rapid detection tools to detect mutations especially those linked to drug-resistance are important to address concerns of the rising multi-drug resistance infections. Here we integrated dual probes, namely a calibrator probe and an indicator probe, into isothermal amplification detection system. These two probes are designed to bind distinct regions on the same amplicon to determine the presence or absence of mutation. The calibrator probe signal is used as an internal signal calibrator for indicator probe which detects the presence or absence of the mutation. As an illustrative example, we evaluated the applicability of this dual probe method for detecting mutations associated with rifampicin (RIF) drug resistance at codons 516, 526 and 531 of the rpoB gene in Mycobacterium tuberculosis. In this assessment, we examined 127 artificial samples comprising wild types and mutants with single or multiple mutations. Our results demonstrated 100% accuracy for both wild types and mutants for mutations at codons 526 and 531. As regards to mutations at codon 516, the wild type was identified with 100% accuracy, while the mutants were identified with 95% accuracy. Moreover, when we extended our evaluation to include clinical MTB strains and the Zeptometrix MTB Verification panel, our method achieved 100% accuracy (5 out of 5) in identifying wild-type strains. Additionally, we successfully detected a RIF-resistant strain with mutations at codon 531 of the rpoB gene in Zeptometrix verification panel. Our isothermal mutation detection system, relying on dual probes exhibits a versatile approach. With the capability to identify mutations without prior knowledge of their specific mutation direction, our dual-probe method shows significant promise for applications in drug resistance nucleic acid testing, particularly in resource-limited settings.